Leap Therapeutics Inc (LPTX) concluded trading on Thursday at a closing price of $3.12, with 5.67 million shares of worth about $17.69 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 94.69% during that period and on April 11, 2024 the price saw a gain of about 2.47%. Currently the company’s common shares owned by public are about 25.57M shares, out of which, 23.43M shares are available for trading.
However, the stock later moved at a day high price of 4.3900, or with a gain of 2.47%. Stock saw a price change of 24.10% in past 5 days and over the past one month there was a price change of 24.60%. Year-to-date (YTD), LPTX shares are showing a performance of -24.85% which increased to 3.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.24 but also hit the highest price of $10.20 during that period. The average intraday trading volume for Leap Therapeutics Inc shares is 240.12K. The stock is currently trading 22.23% above its 20-day simple moving average (SMA20), while that difference is up 10.96% for SMA50 and it goes to 23.72% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Leap Therapeutics Inc (NASDAQ: LPTX) currently have 25.57M outstanding shares and institutions hold larger chunk of about 23.98% of that.
The stock has a current market capitalization of $79.74M and its 3Y-monthly beta is at 0.57. It has posted earnings per share of -$5.12 in the same period. It has Quick Ratio of 5.64 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LPTX, volatility over the week remained 21.80% while standing at 12.90% over the month.
Analysts are in expectations that Leap Therapeutics Inc (LPTX) stock would likely to be making an EPS of -$0.58 in the current quarter, while forecast for next quarter EPS is -$0.62 and it is -$1.96 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.64 which is -$0.56 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$3.2 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 43.40% while it is estimated to increase by 33.85% in next year. EPS is likely to shrink at an annualized rate of -2.49% for next 5-years, compared to annual growth of 28.36% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on October 04, 2021 offering a Buy rating for the stock and assigned a target price of $6 to it. Coverage by Robert W. Baird stated Leap Therapeutics Inc (LPTX) stock as an Outperform in their note to investors on June 04, 2021, suggesting a price target of $5 for the stock. On June 29, 2020, Piper Sandler Initiated their recommendations, while on February 11, 2020, Robert W. Baird Initiated their ratings for the stock with a price target of $6. Stock get a Mkt perform rating from Raymond James on November 15, 2019.
